{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:12:32Z","timestamp":1789524752636,"version":"build-2803163510"},"reference-count":38,"publisher":"Georg Thieme Verlag KG","issue":"07","funder":[{"name":"The Shanghai Municipal Commission of Science and Technology","award":["22JC1403003, 22XD1402200, 22S31903800"],"award-info":[{"award-number":["22JC1403003, 22XD1402200, 22S31903800"]}]},{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82273025, 82203460, 82403010"],"award-info":[{"award-number":["82273025, 82203460, 82403010"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The 2022 Shanghai Eastern Talent Plan Leading Project"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endoscopy"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Routine rectal administration of indomethacin before endoscopic retrograde cholangiopancreatography (ERCP) is recommended for prevention of post-ERCP pancreatitis (PEP). Preliminary evidence suggests that the use of 100 mg of indomethacin can reduce the PEP rate; however, the efficacy of a lower dose for PEP prevention remains uncertain.<\/jats:p>\n                  <jats:p>In this randomized, single-blind, noninferiority trial conducted at four centers in China, patients (aged \u226518 years) who were scheduled to undergo ERCP and had a serum amylase level within the normal range were randomly assigned (1:1) to receive 50 mg or 100 mg rectal indomethacin before ERCP. The primary outcome was the PEP rate.<\/jats:p>\n                  <jats:p>Between September 11 2021 and July 1 2024, 2770 patients were enrolled, with 2562 included for intention-to-treat analysis. PEP occurred in 100 (7.7%) of the 1293 patients in the regular-dose group and 103 (8.1%) of the 1269 patients in the low-dose group (risk difference 0.38%; 95%CI \u20131.71 to 2.47; P = 0.72 for noninferiority).<\/jats:p>\n                  <jats:p>For prevention of PEP, 50 mg of indomethacin was noninferior to 100 mg. The prophylactic use of 50 mg of indomethacin can therefore be considered for PEP prevention in the Chinese population. In addition, for people who have a history of pancreatitis, 100 mg of rectal indomethacin may be preferable for prevention of PEP.<\/jats:p>","DOI":"10.1055\/a-2840-3508","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:35:52Z","timestamp":1778884552000},"page":"689-698","source":"Crossref","is-referenced-by-count":1,"title":["Low-dose rectal indomethacin to prevent post-ERCP pancreatitis: results of a large Chinese multicenter randomized noninferiority trial"],"prefix":"10.1055","volume":"58","clinical-trial-number":[{"clinical-trial-number":"chictr2100051036","registry":"10.18810\/chictr"}],"author":[{"given":"Zhi-Peng","family":"Qi","sequence":"first","affiliation":[{"name":"Zhongshan Hospital Fudan University, China","place":["Shanghai"],"department":["Endoscopy Center"]},{"name":"Fudan University, China","place":["Shanghai"],"department":["Endoscopy Research Institute"]},{"name":"Shanghai Collaborative Innovation Center of Endoscopy, China","place":["Shanghai"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wan","sequence":"first","affiliation":[{"name":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, China","place":["Shanghai"],"department":["Department of Gastroenterology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Jian","family":"Wan","sequence":"additional","affiliation":[{"name":"Shanghai Sixth People\u2019s Hospital, Shanghai Jiao Tong University School of Medicine, China","place":["Shanghai"],"department":["Department of Gastroenterology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang-Han","family":"Chen","sequence":"additional","affiliation":[{"name":"Zhongshan Hospital Fudan University, China","place":["Shanghai"],"department":["Endoscopy Center"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8155-3154","authenticated-orcid":false,"given":"Ming-Yan","family":"Cai","sequence":"additional","affiliation":[{"name":"Zhongshan Hospital Fudan University, China","place":["Shanghai"],"department":["Endoscopy Center"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Li","family":"He","sequence":"additional","affiliation":[{"name":"Xuhui Hospital, Zhongshan Hospital of Fudan University, China","place":["Shanghai"],"department":["Endoscopy Center"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Lun","family":"Cai","sequence":"additional","affiliation":[{"name":"Zhongshan Hospital Fudan University, China","place":["Shanghai"],"department":["Endoscopy Center"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Li","sequence":"additional","affiliation":[{"name":"Zhongshan Hospital Fudan University, China","place":["Shanghai"],"department":["Endoscopy Center"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan-Lin","family":"Li","sequence":"additional","affiliation":[{"name":"Zhongshan Hospital Fudan University, China","place":["Shanghai"],"department":["Endoscopy Center"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Li","family":"Lin","sequence":"additional","affiliation":[{"name":"Zhongshan Hospital Fudan University, China","place":["Shanghai"],"department":["Endoscopy Center"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5434-0540","authenticated-orcid":false,"given":"Ping-Hong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Zhongshan Hospital Fudan University, China","place":["Shanghai"],"department":["Endoscopy Center"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Shi","family":"Zhong","sequence":"additional","affiliation":[{"name":"Zhongshan Hospital Fudan University, China","place":["Shanghai"],"department":["Endoscopy Center"]},{"name":"Xuhui Hospital, Zhongshan Hospital of Fudan University, China","place":["Shanghai"],"department":["Endoscopy Center"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Study Group*","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cgh.2021.08.050","article-title":"A cost-effectiveness analysis for post-endoscopic retrograde cholangiopancreatography pancreatitis prophylaxis in the United States","volume":"20","author":"NR Thiruvengadam","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/jcag\/gwy006","article-title":"Rectal indomethacin prevents moderate to severe post-ERCP pancreatitis and death and should be used before the procedure: a meta-analysis of aggregate subgroup data","volume":"1","author":"M Yaghoobi","year":"2018","journal-title":"J Can Assoc Gastroenterol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gie.2023.03.023","article-title":"Incidence, severity, and mortality of post-ERCP pancreatitis: an updated systematic review and meta-analysis of 145 randomized controlled trials","volume":"98","author":"VS Akshintala","year":"2023","journal-title":"Gastrointest Endosc"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1053\/j.gastro.2016.04.048","article-title":"Rectal indomethacin reduces pancreatitis in high- and low-risk patients undergoing endoscopic retrograde cholangiopancreatography","volume":"151","author":"NR Thiruvengadam","year":"2016","journal-title":"Gastroenterology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114147","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective","volume":"180","author":"S Bindu","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.pop.2014.09.001","article-title":"Nonsteroidal antiinflammatory drugs, cyclooxygenase-2, and the kidneys","volume":"41","author":"S Rahman","year":"2014","journal-title":"Prim Care"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"216","DOI":"10.14740\/gr658w","article-title":"Cross-sectional study for prevalence of non-steroidal anti-inflammatory drug-induced gastrointestinal, cardiac and renal complications in India: interim report","volume":"8","author":"S Chatterjee","year":"2015","journal-title":"Gastroenterology Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S2468-1253(19)30359-0","article-title":"High-dose NSAIDs and pancreatitis after ERCP: more is not always better","volume":"5","author":"SS Rana","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S2468-1253(19)30337-1","article-title":"Rectal indometacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients: a double-blind, randomised controlled trial","volume":"5","author":"EL Fogel","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref10","first-page":"s267","article-title":"Quantifying the impact of NSAID-associated adverse events","volume":"19","author":"M Fine","year":"2013","journal-title":"Am J Manag Care"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"143","DOI":"10.14336\/AD.2017.0306","article-title":"A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly","volume":"9","author":"S Wongrakpanich","year":"2018","journal-title":"Aging Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1080\/00365521.2021.1946134","article-title":"A 25\u2009mg rectal dose of diclofenac for prevention of post-ERCP pancreatitis in elderly patients","volume":"56","author":"N Maeda","year":"2021","journal-title":"Scand J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.2169\/internalmedicine.0554-17","article-title":"The effectiveness of the rectal administration of low-dose diclofenac for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis","volume":"57","author":"M Okuno","year":"2018","journal-title":"Intern Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American Geriatrics Society 2019 updated AGS Beers Criteria for potentially inappropriate medication use in older adults","volume":"67","author":"2019 American Geriatrics Society Beers Criteria Update Expert Panel","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s40272-022-00514-1","article-title":"Efficacy and safety of NSAIDs in infants: a comprehensive review of the literature of the past 20 years","volume":"24","author":"VC Ziesenitz","year":"2022","journal-title":"Paediatr Drugs"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.14309\/ajg.0000000000002903","article-title":"Tailored hydration with lactated Ringer\u2019s solution for postendoscopic retrograde cholangiopancreatography pancreatitis prevention: a randomized controlled trial","volume":"119","author":"E Cho","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.gie.2016.09.037","article-title":"International consensus recommendations for difficult biliary access","volume":"85","author":"WC Liao","year":"2017","journal-title":"Gastrointest Endosc"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1055\/a-1075-4080","article-title":"ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline","volume":"52","author":"JM Dumonceau","year":"2020","journal-title":"Endoscopy"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0016-5107(91)70740-2","article-title":"Endoscopic sphincterotomy complications and their management: an attempt at consensus","volume":"37","author":"PB Cotton","year":"1991","journal-title":"Gastrointest Endosc"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1056\/NEJMoa1111103","article-title":"A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis","volume":"366","author":"BJ Elmunzer","year":"2012","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1002\/sim.1242","article-title":"Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk","volume":"9","author":"CP Farrington","year":"1990","journal-title":"Stat Med"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1001\/jama.2024.23410","article-title":"Oral glucose-lowering agents vs insulin for gestational diabetes: a randomized clinical trial","volume":"333","author":"D Rademaker","year":"2025","journal-title":"JAMA"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0140-6736(23)02356-5","article-title":"Indomethacin with or without prophylactic pancreatic stent placement to prevent pancreatitis after ERCP: a randomised non-inferiority trial","volume":"403","author":"BJ Elmunzer","year":"2024","journal-title":"Lancet"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1053\/j.gastro.2024.10.033","article-title":"Adverse events associated with endoscopic retrograde cholangiopancreatography: systematic review and meta-analysis","volume":"168","author":"K Bishay","year":"2025","journal-title":"Gastroenterology"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1007\/s11605-022-05399-6","article-title":"The incidence and severity of post-ERCP pancreatitis in patients receiving standard administration of NSAIDs: a systematic review and meta-analysis","volume":"26","author":"X Kang","year":"2022","journal-title":"J Gastrointest Surg"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1007\/s00535-012-0554-7","article-title":"Low-dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trial","volume":"47","author":"T Otsuka","year":"2012","journal-title":"J Gastroenterol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12876-025-03690-9","article-title":"Systematic review and meta-analysis: no evidence that low-dose non-steroidal anti-inflammatory drugs (NSAIDs) reduce the risk of pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP)","volume":"25","author":"W Li","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1136\/gutjnl-2024-334466","article-title":"Rectal diclofenac versus indomethacin for prevention of post-ERCP pancreatitis (DIPPP): a multicentre, double-blind, randomised, controlled trial","volume":"74","author":"X Kang","year":"2025","journal-title":"Gut"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"46650","DOI":"10.1038\/srep46650","article-title":"Efficacy and safety of rectal nonsteroidal anti-inflammatory drugs for prophylaxis against post-ERCP pancreatitis: a systematic review and meta-analysis","volume":"7","author":"YC Hou","year":"2017","journal-title":"Sci Rep"},{"key":"ref30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092922","article-title":"How and when should NSAIDs be used for preventing post-ERCP pancreatitis? A systematic review and meta-analysis","volume":"9","author":"I Puig","year":"2014","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1055\/s-0034-1377875","article-title":"Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline \u2013 updated June 2014","volume":"46","author":"JM Dumonceau","year":"2014","journal-title":"Endoscopy"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/2047-783X-19-26","article-title":"Risk factors for post-ERCP pancreatitis: a systematic review of clinical trials with a large sample size in the past 10 years","volume":"19","author":"JJ Chen","year":"2014","journal-title":"Eur J Med Res"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.surge.2014.11.005","article-title":"Risk factors for post-ERCP pancreatitis: a systematic review and meta-analysis","volume":"13","author":"X Ding","year":"2015","journal-title":"Surgeon"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/ajg.2012.442","article-title":"Does rectal indomethacin eliminate the need for prophylactic pancreatic stent placement in patients undergoing high-risk ERCP? Post hoc efficacy and cost-benefit analyses using prospective clinical trial data","volume":"108","author":"BJ Elmunzer","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.cgh.2012.12.043","article-title":"Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis","volume":"11","author":"A Akbar","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1055\/s-0030-1255781","article-title":"Prophylactic pancreatic stent placement and post-ERCP pancreatitis: a systematic review and meta-analysis","volume":"42","author":"T Mazaki","year":"2010","journal-title":"Endoscopy"},{"key":"ref37","first-page":"618","article-title":"Current status of endoscopic stenting of the pancreatic duct as prophylaxis against post-ERCP pancreatitis","volume":"8","author":"ML Freeman","year":"2012","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"ref38","first-page":"302","article-title":"Pancreatic duct stent combined with indomethacin suppository for prevention of pancreatitis after difficult bile duct intubation during endoscopic retrograde cholangiopancreatography","volume":"40","author":"S Zhihu","year":"2023","journal-title":"Chin J Dig Endosc"}],"container-title":["Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2840-3508.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T22:42:05Z","timestamp":1782168125000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2840-3508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":38,"journal-issue":{"issue":"07","published-online":{"date-parts":[[2026,6,22]]},"published-print":{"date-parts":[[2026,7]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2840-3508","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0013-726X","1438-8812"],"issn-type":[{"value":"0013-726X","type":"print"},{"value":"1438-8812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]}}}